CTRx^® by Myonex: Real-World Solutions for Smarter Drug Access in Clinical Trials

Providing medication directly to patients: a better trial experience

In this video, Samit Bhatt, Vice President, Pharmacy Services at Myonex, introduces how CTRx enables both global sourcing and centralized local sourcing via prescription cards.

In the US, using CTRx’s pharmacy card, patients can fill prescriptions for sponsor-funded medication access at their local pharmacy. At the same time, standard-of-care or even investigational commercial drugs can be shipped directly to patients’ homes by a central pharmacy.

The result? Better patient experience and greater flexibility for sponsors.

Watch how CTRx supports multiple delivery models while simplifying your supply.

CTRx in a 2,000-patient oncology trial: “The patients love it.”

Industry expert Todd Luckritz shares insights from a Phase IV prostate cancer trial using CTRx. With 2,000 patients across 200 sites, the sponsor chose a direct-to-patient model, with a central pharmacy shipment straight to patients’ homes.

Feedback from both patients and sites has been overwhelmingly positive. Patients no longer need to travel for drug pick-up, and sites are freed from managing dispensing and accountability tasks. CTRx handles it all: inventory, records, and destruction, reducing site burden.

See why sites and patients are embracing CTRx.

Maintaining Patient Enrollment by Saving Patient Costs and Eliminating the Need to Travel to Site

In this clinical study, the sponsor was committed to removing access barriers for patients who required insulin. Rather than asking patients to rely on insurance or make extra site visits, they wanted a simpler, patient-friendly solution.

Centrally sourcing insulin wasn’t realistic as every patient’s dosage needs are different. So, the sponsor turned to the CTRx prescription card service in the US.

With CTRx, patients were able to get their insulin directly from their trusted local pharmacy, free of charge, without having to travel or use personal insurance.

Easier access and better patient experience led to faster-than-expected enrollment.

Watch how CTRx improves access and accelerates recruitment.

Stay ready for first-patient, first-dose without overspending or overstocking: adopt CTRx

Racheal Yoon, Associate Director of Pharmacy Services at Myonex, shares what she sees time and again: sponsors bulk-purchasing expensive drugs upfront, only to face delays, protocol amendments, or shifting enrollment.

Her answer? CTRx, a smarter, more adaptive approach to trial drug supply.

Racheal breaks down how CTRx:

• Helps avoid bulk purchasing and costly drug waste
• Enables faster trial startup and improves patient access
• Is fully integrable with other Myonex clinical services

Watch the expert clip to learn how CTRx gives sponsors the control, flexibility, and cost-efficiency they need without compromising timelines.